Trade 335

INVALID CRM

0 shares at $187.27 on 2026-05-05

Reasoning

[REJECTED: no price available] CRM thesis #238 intact. Stock at $187.28 trading at ~20x P/E vs. software average 30x—significant value gap. May 27 earnings (3 weeks out) is next binary event. Barclays identified as leading infrastructure software play; Google Cloud partnership expanding Agentforce integration provides fundamental support. Post-today's buy, position is ~0.82 shares. Adding $150 (modest sizing) ahead of earnings is justified but position kept intentionally small given binary risk. Corroborating macro and news signals present (Rule #39 satisfied).

Thesis

Salesforce approaching May 26-27 earnings binary event. CRM is now trading below the $170 invalidation level on hot CPI data driving broad tech selloff and Citigroup lowering its price target. The original thesis of SaaS momentum and Agentforce traction remains but the macro environment has shifted materially against growth/tech names with CPI at 3.8% and rate cut expectations evaporating. The position is underwater significantly. Risk-reward ahead of earnings is now asymmetric to the downside given macro headwinds and deteriorating price action. (long, low confidence)

Cited evidence

News

Macro